California Pacific Medical Center Research Institute
45
4
5
30
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.7%
3 terminated/withdrawn out of 45 trials
90.9%
+4.3% vs industry average
9%
4 trials in Phase 3/4
7%
2 of 30 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (45)
Targeting Aging With a Ketone Ester for Function in Frailty
Role: collaborator
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
Role: lead
Trial of Parkinson's And Zoledronic Acid
Role: lead
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
Role: lead
Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling
Role: collaborator
CBT-I or Zolpidem/Trazodone for Insomnia
Role: lead
The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).
Role: lead
The PERFusion Use in Stroke Evaluation Study
Role: lead
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
Role: lead
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
Role: lead
The Impact of Workplace Food and Beverage Choices on Health and Wellness
Role: lead
CPMC Early Undifferentiated Arthritis Registry
Role: lead
Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation
Role: lead
Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain
Role: collaborator
Maternal, Adiposity, Metabolism, and Stress Study
Role: collaborator
Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic
Role: lead
Mindfulness and Migraine Research Study
Role: lead
Submucosal Injection EMR vs. Underwater EMR for Colorectal Polyps
Role: lead
EUS-Guided Rendezvous or Direct Interventions Versus Advanced ERCP Techniques for Biliary Access and Therapy
Role: lead
Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
Role: collaborator